Eiichi Ogawa

31PUBLICATIONS
90CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 14, 2026
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

|Jan 19, 2026
Reply to "Concerns Regarding the Paradoxical Renal Outcomes in Patients Switching From Entecavir to Tenofovir Alafenamide".

Eiichi Ogawa

|Aug 09, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi

|Jun 04, 2025
Differential HCC risk among HBV indeterminate types at baseline and by phase transition.

Rui Huang, Huy N Trinh, Satoshi Yasuda

|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Rui Huang, Ai-Thien Do, Hidenori Toyoda

|Feb 03, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting Antivirals.

Eiichi Ogawa, Akira Kawano, Motoyuki Kohjima

Pageof 6

Frequent Collaborators

9 joint publications

Mindie Nguyen

9 joint publications

Ming-Lung Yu

6 joint publications

Dae Won Jun

6 joint publications

Hidenori Toyoda